Is Intralymphatic Allergen Immunotherapy Effective and Safe?

Clinical trial NCT04210193 · COMPLETED

Trial details

NCT number: NCT04210193
Sponsor: Lars Olaf Cardell
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis Due to Grass Pollen

Start date: 2014-04-25
Primary completion: 2019-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.